🔗 Share this article

Treasury head Rachel Reeves has stated she is preparing "targeted steps to deal with cost of living challenges" in the upcoming financial statement.

Speaking to the BBC, she emphasized that reducing inflation is a joint duty of both the government and the central bank.

The United Kingdom's inflation rate is projected to be the highest among the G7 advanced economies this calendar year and next.

Possible Energy Cost Interventions

It is understood the government could intervene to bring down utility costs, such as by cutting the current 5% rate of VAT applied on energy supplies.

A further approach is to cut some of the regulatory levies currently included in bills.

Budgetary Limitations and Analyst Expectations

The administration will receive the next report from the official forecaster, the Office for Budget Responsibility, on Monday, which will clarify how much room there is for these measures.

The view from the majority of economists is that Reeves will have to announce tax increases or budget cuts in order to meet her voluntary borrowing rules.

Previously on Thursday, estimates suggested there was a twenty-two billion pound deficit for the Treasury chief to fill, which is at the lower end of expectations.

"It is a collective job between the Bank of England and the government to bear down further on some of the drivers of inflation," the Chancellor informed the BBC in the US capital, at the conferences of the IMF and global financial institution.

Revenue Pledges and Global Concerns

While much of the attention has been on likely tax rises, the Treasury chief said the latest figures from the fiscal watchdog had not altered her pledge to campaign commitments not to raise tax levels on income tax, sales tax or social security contributions.

She attributed an "unpredictable global environment" with rising geopolitical and commercial concerns for the fiscal revenue measures, probably to be directed on those "most able to pay."

International Economic Disputes

Addressing worries about the UK's trade ties with the Asian nation she said: "The UK's national security always take priority."

Recent statement by China to strengthen export controls on rare earths and other resources that are crucial for advanced tech manufacturing led American leader Donald Trump to threaten an further 100% tariff on imports from China, raising the risk of an full-scale trade war between the two economic giants.

The American finance chief called China's move "economic coercion" and "a international production power grab."

Inquired about accepting the US offer to participate in its battle with the Asian nation, Reeves said she was "extremely troubled" by Chinese measures and urged the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "damaging for the world economy and causes further challenges."

"It is my opinion there are areas where we must address Chinese policies, but there are also important opportunities to trade with Chinese markets, including financial services and other areas of the economic system. We've got to achieve that equilibrium correct."

The chancellor also stated she was working with G7 counterparts "on our own essential resources strategy, so that we are more independent."

Health Service Medicine Pricing and Funding

Reeves also admitted that the price the National Health Service pays for pharmaceuticals could go up as a result of current negotiations with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and capital.

Some of the world's largest pharmaceutical manufacturers have said recently that they are either delaying or abandoning projects in the UK, with several blaming the low prices they are obtaining.

Last month, the government science advisor said the cost the health service spends on drugs would need to rise to prevent firms and pharmaceutical investment departing from the United Kingdom.

Reeves informed the BBC: "We have seen because of the pricing regime, that drug testing, recent pharmaceuticals have not been offered in the UK in the way that they are in other EU nations."

"We want to ensure that patients getting care from the National Health Service are can receive the finest life-saving medicines in the globe. And so we are examining this situation, and... looking to secure additional capital into the UK."